Neisseria gonorrhoeae

Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to Neisseria gonorrhoeae: Neisseria meningitidis
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Neisseria gonorrhoeae - the pus-producing bacterium that causes gonorrheaNeisseria gonorrhoeae - the pus-producing bacterium that causes gonorrhea
bacteria, bacterium - (microbiology) single-celled or noncellular spherical or spiral or rod-shaped organisms lacking chlorophyll that reproduce by fission; important as pathogens and for biochemical properties; taxonomy is difficult; often considered to be plants
References in periodicals archive ?
PART 1 Supply of Automated Molecular Diagnostics Equipment and Reagentsfor the Qualitative detection of Chlamydia trachomatis DNA & Neisseria gonorrhoeae DNA.
NEW YORK, March 9, 2015 /PRNewswire/ -- Summary Global Markets Direct's, 'Neisseria Gonorrhoeae Infections - Pipeline Review, H1 2015', provides an overview of the Neisseria Gonorrhoeae Infections's therapeutic pipeline.
This study characterises the Neisseria gonorrhoeae culture collection strains available from Institute of Environmental Science and Research (ESR) in Kenepuru, New Zealand by three molecular assays designed to predict resistance or reduced susceptibility.
A diagnosis of suspected urethritis caused by Neisseria gonorrhoeae was made, and a sample of the urethral discharge was sent for culture and testing (Strand Displacement Amplification) for N.
x] Amplified DNA Assays are designed to meet the needs of today's clinical laboratories, providing automated, accurate and reliable detection of Chlamydia trachomatis and Neisseria gonorrhoeae, for all genital sample types," said Doug White, Vice President, General Manager, Molecular Diagnostics & Women's Health, BD Diagnostics - Diagnostic Systems.
The bacterium organism Neisseria gonorrhoeae has evolved in the direction of developing resistance to antibiotics, including sulfonamides, penicillin, tetracycline, and fluoroquinolones.
study with about 400 patients, providing solid evidence for the potential of both combinations as backup treatments for Neisseria gonorrhoeae at a time when resistance in the pathogen has whittled standard treatment options down to one primary drug, ceftriaxone.
The topics include transmembrane molecular transporters facilitating export of molecules from cells and organelles, the machinery and mechanism of multi-drug efflux in Gram-negative bacteria, the role of efflux pumps in the nosocomial pathogens Staphylococcus aureus and Acinotobacter baumannii, Salmonella efflux pumps, and the function and regulation of Neisseria gonorrhoeae efflux pumps.
Gonorrhoea is an infection caused by the neisseria gonorrhoeae bacterium that leads to genital inflammation along with discharge and cystitis.
HPA experts say the STI has been easy to treat for the last 70 years but the organism that causes the infection - Neisseria gonorrhoeae - has an unusual ability to adapt itself and has gained resistance to a growing list of antibiotics, from penicillin to tetracyclines, ciprofloxacin and now cefixime.
The bacterium that causes the infection - Neisseria gonorrhoeae - has an unusual ability to adapt itself and has gained resistance, or reduced susceptibility, to a growing list of antibiotics - first penicillin itself, then tetracyclines, ciprofloxacin and now cefixime.